Logo image of ECL

ECOLAB INC (ECL) Stock Analyst Ratings

NYSE:ECL - New York Stock Exchange, Inc. - US2788651006 - Common Stock - Currency: USD

238.73  +2.77 (+1.17%)

After market: 238.73 0 (0%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to ECL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 294.13. This target is 23.21% above the current price.
ECL was analyzed by 31 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about ECL.
In the previous month the buy percentage consensus was at a similar level.
ECL was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
ECL Historical Analyst RatingsECL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 10 20 30

Price Target & Forecast

Price Low Median Mean High 238.73235.29299.88294.13328.65 - -1.44% 25.61% 23.21% 37.67%
ECL Current Analyst RatingECL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10
Up and Down Grades
Date Firm Action Rating
2025-04-17 Barclays Maintains Overweight -> Overweight
2025-04-16 Wells Fargo Downgrade Overweight -> Equal-Weight
2025-04-15 Mizuho Maintains Outperform -> Outperform
2025-04-09 Wells Fargo Maintains Overweight -> Overweight
2025-04-08 Citigroup Maintains Buy -> Buy
2025-03-24 Redburn Atlantic Downgrade Buy -> Neutral
2025-03-03 BMO Capital Maintains Outperform -> Outperform
2025-02-24 Piper Sandler Maintains Overweight -> Overweight
2025-02-12 UBS Maintains Neutral -> Neutral
2025-02-12 Stifel Maintains Buy -> Buy
2025-02-12 Wells Fargo Maintains Overweight -> Overweight
2025-02-12 Citigroup Maintains Buy -> Buy
2025-01-28 Morgan Stanley Upgrade Equal-Weight -> Overweight
2025-01-10 RBC Capital Maintains Outperform -> Outperform
2025-01-07 Piper Sandler Maintains Overweight -> Overweight
2024-12-17 BMO Capital Upgrade Market Perform -> Outperform
2024-11-18 Barclays Maintains Overweight -> Overweight
2024-11-04 UBS Downgrade Buy -> Neutral
2024-10-30 BMO Capital Maintains Market Perform -> Market Perform
2024-10-30 RBC Capital Reiterate Outperform -> Outperform
2024-10-30 JP Morgan Maintains Neutral -> Neutral
2024-10-30 Baird Maintains Neutral -> Neutral
2024-10-30 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-10-18 Jefferies Upgrade Hold -> Buy
2024-10-07 Wells Fargo Maintains Overweight -> Overweight
2024-09-30 BMO Capital Maintains Market Perform -> Market Perform
2024-09-26 Piper Sandler Maintains Overweight -> Overweight
2024-09-16 RBC Capital Maintains Outperform -> Outperform
2024-08-21 RBC Capital Reiterate Outperform -> Outperform
2024-08-15 UBS Maintains Buy -> Buy